Monogram Technologies to Participate in the 37th Annual ROTH Conference in California March 16-18, 2025
Monogram Technologies (NASDAQ: MGRM), an AI-driven robotics company specializing in orthopedic surgery solutions, has announced its participation in the upcoming 37th Annual ROTH Conference. The event will take place from March 16-18, 2025, at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California.
The company will be represented by CEO Ben Sexson and CFO Noel Knape, who will conduct one-on-one meetings with institutional investors during this invitation-only event. Interested investors can schedule meetings through their conference representatives or by contacting MGRM@mzgroup.us or Chris Tyson at (949) 491-8235.
Monogram Technologies (NASDAQ: MGRM), un'azienda di robotica guidata dall'IA specializzata in soluzioni per la chirurgia ortopedica, ha annunciato la sua partecipazione al prossimo 37° Annual ROTH Conference. L'evento si svolgerà dal 16 al 18 marzo 2025, presso il Laguna Cliffs Marriott Resort & Spa a Dana Point, California.
L'azienda sarà rappresentata dal CEO Ben Sexson e dal CFO Noel Knape, che condurranno incontri individuali con investitori istituzionali durante questo evento su invito. Gli investitori interessati possono programmare incontri tramite i rappresentanti della conferenza o contattando MGRM@mzgroup.us o Chris Tyson al (949) 491-8235.
Monogram Technologies (NASDAQ: MGRM), una empresa de robótica impulsada por IA especializada en soluciones de cirugía ortopédica, ha anunciado su participación en la próxima 37ª Conferencia Anual ROTH. El evento se llevará a cabo del 16 al 18 de marzo de 2025, en el Laguna Cliffs Marriott Resort & Spa en Dana Point, California.
La empresa estará representada por el CEO Ben Sexson y el CFO Noel Knape, quienes llevarán a cabo reuniones uno a uno con inversores institucionales durante este evento solo por invitación. Los inversores interesados pueden programar reuniones a través de sus representantes de la conferencia o contactando a MGRM@mzgroup.us o a Chris Tyson al (949) 491-8235.
모노그램 테크놀로지스 (NASDAQ: MGRM), 정형외과 수술 솔루션을 전문으로 하는 AI 기반 로봇 회사가 다가오는 제37회 연례 ROTH 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 3월 16일부터 18일까지 캘리포니아 다나 포인트에 위치한 라구나 클리프스 메리어트 리조트 & 스파에서 개최됩니다.
회사는 CEO 벤 섹슨과 CFO 노엘 크네이프가 참석하여 초대 전용 행사에서 기관 투자자들과 일대일 회의를 진행할 예정입니다. 관심 있는 투자자는 회의 대표를 통해 회의를 예약하거나 MGRM@mzgroup.us 또는 크리스 타이슨(949) 491-8235에 연락하여 일정을 잡을 수 있습니다.
Monogram Technologies (NASDAQ: MGRM), une entreprise de robotique alimentée par l'IA spécialisée dans les solutions de chirurgie orthopédique, a annoncé sa participation à la prochaine 37e Conférence Annuelle ROTH. L'événement se déroulera du 16 au 18 mars 2025, au Laguna Cliffs Marriott Resort & Spa à Dana Point, Californie.
L'entreprise sera représentée par CEO Ben Sexson et CFO Noel Knape, qui mèneront des réunions individuelles avec des investisseurs institutionnels lors de cet événement sur invitation uniquement. Les investisseurs intéressés peuvent programmer des réunions par l'intermédiaire de leurs représentants de conférence ou en contactant MGRM@mzgroup.us ou Chris Tyson au (949) 491-8235.
Monogram Technologies (NASDAQ: MGRM), ein von KI betriebenes Robotikunternehmen, das sich auf orthopädische chirurgische Lösungen spezialisiert hat, hat seine Teilnahme an der bevorstehenden 37. jährlichen ROTH-Konferenz angekündigt. Die Veranstaltung findet vom 16. bis 18. März 2025 im Laguna Cliffs Marriott Resort & Spa in Dana Point, Kalifornien, statt.
Das Unternehmen wird durch CEO Ben Sexson und CFO Noel Knape vertreten, die während dieser nur auf Einladung stattfindenden Veranstaltung Einzelgespräche mit institutionellen Investoren führen werden. Interessierte Investoren können über ihre Konferenzvertreter oder durch Kontaktaufnahme mit MGRM@mzgroup.us oder Chris Tyson unter (949) 491-8235 Meetings vereinbaren.
- None.
- None.
AUSTIN, TX / ACCESS Newswire / March 5, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced that Chief Executive Officer Ben Sexson and Chief Financial Officer Noel Knape will participate in the 37th Annual ROTH Conference at the Laguna Cliffs Marriott Resort & Spa in Dana Point, CA March 16-18, 2025.
Mr. Sexson and Mr. Knape will hold one-on-one meetings with institutional investors on site during this annual invitation-only event.
37th Annual ROTH Conference
Date: March 16-18, 2025
Location: Laguna Cliffs Marriott Resort & Spa in Dana Point, CA
Attendees: Chief Executive Officer Ben Sexson and Chief Financial Officer Noel Knape
Format: In-person 1x1's
Conference Website: Click here
For more information on the 37th Annual ROTH Conference or to schedule a one-on-one meeting with Monogram management, please contact your conference representative or you may also email your request to MGRM@mzgroup.us or call Chris Tyson at (949) 491-8235.
About Monogram Technologies Inc.
Monogram Technologies (NASDAQ:MGRM) is an AI-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and next-generation robotics.
Monograms mBôs precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The goal is well balanced, better-fitting bone sparing knee replacements. The Company initially intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. Other clinical and commercial applications for the mBôs with mVision navigation are also being explored.
Monogram has obtained FDA clearance for mPress implants and applied for 510(k) clearance for its robotic products. The Company is required to obtain FDA clearance before it can market its products. Monogram cannot estimate the timing or assure the ability to obtain such clearances.
The Company believes that its mBôs precision robotic surgical assistants, which combine AI and novel navigation methods (mVision), will enable more personalized knee implants for patients, resulting in well balanced better-fitting knee replacements with bone sparing implants. Monogram anticipates that there may be other clinical and commercial applications for its navigated mBôs precision robot and mVision navigation.
To learn more, visit www.monogramtechnologies.com.
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties.. Forward-looking statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that the Company may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements as a result of a number of factors, including those described in the prospectus and the Company's other filings with the SEC. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Investor Relations
Chris Tyson
Executive Vice President
MZ North America
Direct: 949-491-8235
MGRM@mzgroup.us
SOURCE: Monogram Technologies Inc.
View the original press release on ACCESS Newswire
FAQ
When and where is Monogram Technologies (MGRM) presenting at the ROTH Conference 2025?
How can investors schedule meetings with MGRM management at the ROTH Conference?
Which Monogram Technologies executives will attend the 2025 ROTH Conference?
What type of meetings will MGRM conduct at the ROTH Conference 2025?
What is Monogram Technologies' (MGRM) primary business focus?
